Related Experiment Video
Updated: May 10, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Rectus Sheath Hematoma as a Cutaneous Manifestation of Essential Thrombocythemia
Shin Iinuma1,2, Takahiro Kobayashi1, Takahiro Nagashima3
1Dermatology, Japanese Red Cross Kitami Hospital, Kitami, JPN.
Rectus sheath hematoma (RSH) is a rare cause of acute abdominal pain that is often associated with trauma, anticoagulant therapy, or coagulopathy. We present a unique case of an RSH as a cutaneous manifestation of essential thrombocythemia (ET), which is a myeloproliferative neoplasm characterized by thrombotic and hemorrhagic complications. A 66-year-old female patient presented with acute lower abdominal pain, a subcutaneous mass, and overlying skin ecchymosis. Imaging confirmed a significant RSH. Laboratory tests revealed severe anemia and marked thrombocytosis. Further evaluations, including bone marrow biopsy and genetic testing, revealed ET with a CALR mutation. RSH was managed conservatively, and cytoreductive therapy comprising hydroxyurea was administered for ET, resulting in resolution of the hematoma and improvement in hematological parameters. This case highlights the necessity of considering hematological disorders when patients present with spontaneous hematomas. Prompt diagnosis and effective management of both the hematoma and ET were achieved, demonstrating that timely recognition and appropriate treatment are important to improving patient outcomes.
Rectus sheath hematoma (RSH) is a rare cause of acute abdominal pain that is often associated with trauma, anticoagulant therapy, or coagulopathy. We present a unique case of an RSH as a cutaneous manifestation of essential thrombocythemia (ET), which is a myeloproliferative neoplasm characterized by thrombotic and hemorrhagic complications. A 66-year-old female patient presented with acute lower abdominal pain, a subcutaneous mass, and overlying skin ecchymosis. Imaging confirmed a significant RSH. Laboratory tests revealed severe anemia and marked thrombocytosis. Further evaluations, including bone marrow biopsy and genetic testing, revealed ET with a CALR mutation. RSH was managed conservatively, and cytoreductive therapy comprising hydroxyurea was administered for ET, resulting in resolution of the hematoma and improvement in hematological parameters. This case highlights the necessity of considering hematological disorders when patients present with spontaneous hematomas. Prompt diagnosis and effective management of both the hematoma and ET were achieved, demonstrating that timely recognition and appropriate treatment are important to improving patient outcomes.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

